#BEGIN_DRUGCARD DB04224

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
112-80-1

# ChEBI_ID:
16196

# Chemical_Formula:
C18H34O2

# Chemical_IUPAC_Name:
(9E)-octadec-9-enoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
An unsaturated fatty acid that is the most widely distributed and abundant fatty acid in nature. It is used commercially in the preparation of oleates and lotions, and as a pharmaceutical solvent. (Stedman, 26th ed)

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Oleic Acid

# HET_ID:
OLA

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H,19,20)/b10-9+

# InChI_Key:
InChIKey=ZQPPMHVWECSIRJ-MDZDMXLPSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00712

# KEGG_Drug_ID:
D02315

# LIMS_Drug_ID:
4224

# Mechanism_Of_Action:
Not Available

# Melting_Point:
13.4 Â°C

# Molecular_Weight_Avg:
282.4614

# Molecular_Weight_Mono:
282.255880332

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1SX6

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
7.68

# Predicted_LogS:
-6.4

# Predicted_Water_Solubility:
1.21e-04 g/l

# Primary_Accession_No:
DB04224

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
637517

# PubChem_Substance_ID:
46506835

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02430

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CCCCCCCC\C=C\CCCCCCCC(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:06 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
GLTP

# Drug_Target_1_GenBank_ID_Gene:
AF209704

# Drug_Target_1_GenBank_ID_Protein:
6959686

# Drug_Target_1_GeneCard_ID:
GLTP

# Drug_Target_1_Gene_Name:
GLTP

# Drug_Target_1_Gene_Sequence:
>630 bp
ATGGCGCTGCTGGCGGAGCACTTGCTGAAGCCGCTGCCCGCGGACAAGCAGATCGAGACC
GGGCCCTTCCTCGAGGCGGTGTCCCACCTGCCGCCCTTCTTCGATTGCCTTGGGTCCCCA
GTGTTTACTCCCATCAAGGCAGACATAAGCGGCAACATCACGAAAATCAAAGCTGTGTAC
GACACCAACCCAGCCAAGTTCCGGACCCTGCAGAACATCCTGGAGGTGGAGAAAGAAATG
TATGGAGCAGAGTGGCCCAAAGTAGGGGCCACACTGGCGCTGATGTGGCTGAAAAGAGGC
CTCCGCTTCATCCAGGTCTTCCTCCAGAGCATCTGCGACGGGGAGCGGGACGAGAACCAC
CCCAACCTCATCCGTGTCAACGCCACCAAGGCCTACGAGATGGCCCTCAAGAAGTACCAT
GGCTGGATCGTGCAGAAGATCTTCCAGGCAGCACTGTACGCAGCACCCTATAAGTCTGAC
TTCCTGAAAGCGCTCTCCAAGGGGCAGAATGTTACGGAGGAGGAGTGCCTGGAGAAGATC
CGCCTCTTCCTAGTCAACTACACGGCGACCATCGATGTCATCTACGAGATGTACACCCAG
ATGAACGCTGAGCTCAACTACAAGGTGTAG

# Drug_Target_1_General_Function:
Involved in glycolipid binding

# Drug_Target_1_General_References:
Not Available

# Drug_Target_1_HGNC_ID:
HGNC:24867

# Drug_Target_1_HPRD_ID:
16409

# Drug_Target_1_ID:
3382

# Drug_Target_1_Locus:
12q24.11

# Drug_Target_1_Molecular_Weight:
23850

# Drug_Target_1_Name:
Glycolipid transfer protein

# Drug_Target_1_Number_of_Residues:
209

# Drug_Target_1_PDB_ID:
1SX6

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
Not Available

# Drug_Target_1_Protein_Sequence:
>Glycolipid transfer protein
MALLAEHLLKPLPADKQIETGPFLEAVSHLPPFFDCLGSPVFTPIKADISGNITKIKAVY
DTNPAKFRTLQNILEVEKEMYGAEWPKVGATLALMWLKRGLRFIQVFLQSICDGERDENH
PNLIRVNATKAYEMALKKYHGWIVQKIFQAALYAAPYKSDFLKALSKGQNVTEEECLEKI
RLFLVNYTATIDVIYEMYTQMNAELNYKV

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Accelerates the intermembrane transfer of various glycolipids. Catalyzes the transfer of various glycosphingolipids and glyceroglycolipids between membranes but does not catalyze the transfer of phospholipids. It is possible that it is involved in the intracellular translocation of glucosylceramides

# Drug_Target_1_SwissProt_ID:
Q9NZD2

# Drug_Target_1_SwissProt_Name:
GLTP_HUMAN

# Drug_Target_1_Synonyms:
GLTP

# Drug_Target_1_Theoretical_pI:
7.49

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasm

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
M60895

# Drug_Target_2_GenBank_ID_Protein:
160984

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
Not Available

# Drug_Target_2_Gene_Sequence:
>402 bp
ATGTCTAGTTTCTTGGGAAAGTGGAAACTTAGCGAGTCACACAACTTCGATGCTGTCATG
TCAAAGCTAGGTGTCTCATGGGCAACTCGACAGATTGGGAACACAGTGACCCCAACTGTA
ACCTTCACAATGGATGGGGATAAAATGACTATGTTAACAGAGTCAACTTTCAAAAATCTT
TCTTGTACGTTCAAGTTCGGCGAGGAATTCGATGAAAAAACAAGTGACGGCAGAAATGTC
AAGTCAGTTGTTGAAAAAAATTCCGAGTCGAAGTTAACGCAAACTCAAGTAGATCCCAAA
AACACAACTGTAATCGTTCGTGAAGTGGATGGTGATACTATGAAAACGACTGTGACTGTT
GGTGACGTTACTGCCATTCGCAATTATAAACGACTATCCTAA

# Drug_Target_2_General_Function:
Involved in fatty acid binding

# Drug_Target_2_General_References:
2022660	Moser D, Tendler M, Griffiths G, Klinkert MQ: A 14-kDa Schistosoma mansoni polypeptide is homologous to a gene family of fatty acid binding proteins. J Biol Chem. 1991 May 5;266(13):8447-54.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2853

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
14848

# Drug_Target_2_Name:
14 kDa fatty acid-binding protein

# Drug_Target_2_Number_of_Residues:
133

# Drug_Target_2_PDB_ID:
1VYG

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00061	Lipocalin

# Drug_Target_2_Protein_Sequence:
>14 kDa fatty acid-binding protein
MSSFLGKWKLSESHNFDAVMSKLGVSWATRQIGNTVTPTVTFTMDGDKMTMLTESTFKNL
SCTFKFGEEFDEKTSDGRNVKSVVEKNSESKLTQTQVDPKNTTVIVREVDGDTMKTTVTV
GDVTAIRNYKRLS

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
May play a role in the transport of fatty acids. Binds to palmitic and linolenic acids (in vitro)

# Drug_Target_2_SwissProt_ID:
P29498

# Drug_Target_2_SwissProt_Name:
FABP_SCHMA

# Drug_Target_2_Synonyms:
Sm14

# Drug_Target_2_Theoretical_pI:
8.49

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
8

# Drug_Target_3_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
X62167

# Drug_Target_3_GenBank_ID_Protein:
35186

# Drug_Target_3_GeneCard_ID:
PMP2

# Drug_Target_3_Gene_Name:
PMP2

# Drug_Target_3_Gene_Sequence:
>399 bp
ATGAGCAACAAATTCCTGGGCACCTGGAAACTTGTCTCTAGCGAGAACTTTGACGATTAC
ATGAAAGCTCTGGGTGTGGGGTTAGCCACCAGAAAACTGGGAAATTTGGCCAAACCCACT
GTGATCATCAGCAAGAAAGGAGATATTATAACTATACGAACTGAAAGTACCTTTAAAAAT
ACAGAAATCTCCTTCAAGCTAGGCCAGGAATTTGAAGAAACCACAGCTGACAATAGAAAG
ACCAAGAGCATCGTAACCCTGCAGAGAGGATCACTGAATCAAGTGCAGAGATGGGATGGC
AAAGAGACAACCATAAAGAGAAAGCTAGTGAATGGGAAAATGGTAGCGGAATGTAAAATG
AAGGGCGTGGTGTGCACCAGAATCTATGAGAAGGTCTGA

# Drug_Target_3_General_Function:
Involved in lipid binding

# Drug_Target_3_General_References:
15489334	Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.
1720307	Hayasaka K, Nanao K, Tahara M, Sato W, Takada G, Miura M, Uyemura K: Isolation and sequence determination of cDNA encoding P2 protein of human peripheral myelin. Biochem Biophys Res Commun. 1991 Nov 27;181(1):204-7.
6183401	Suzuki M, Kitamura K, Sakamoto Y, Uyemura K: The complete amino acid sequence of human P2 protein. J Neurochem. 1982 Dec;39(6):1759-62.
7525873	Narayanan V, Ripepi B, Jabs EW, Hawkins A, Griffin C, Tennekoon G: Partial structure and mapping of the human myelin P2 protein gene. J Neurochem. 1994 Dec;63(6):2010-3.

# Drug_Target_3_HGNC_ID:
GNC:9117

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
6677

# Drug_Target_3_Locus:
8q21.3-q22.1

# Drug_Target_3_Molecular_Weight:
14909.3

# Drug_Target_3_Name:
Myelin P2 protein

# Drug_Target_3_Number_of_Residues:
132

# Drug_Target_3_PDB_ID:
Not Available

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00061	Lipocalin

# Drug_Target_3_Protein_Sequence:
>Myelin P2 protein
MSNKFLGTWKLVSSENFDDYMKALGVGLATRKLGNLAKPTVIISKKGDIITIRTESTFKN
TEISFKLGQEFEETTADNRKTKSIVTLQRGSLNQVQRWDGKETTIKRKLVNGKMVAECKM
KGVVCTRIYEKV

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
May play a role in lipid transport protein in Schwann cells

# Drug_Target_3_SwissProt_ID:
P02689

# Drug_Target_3_SwissProt_Name:
MYP2_HUMAN

# Drug_Target_3_Synonyms:
Not Available

# Drug_Target_3_Theoretical_pI:
10.55

# Drug_Target_3_Transmembrane_Regions:
None

#END_DRUGCARD DB04224
